| 英文摘要 |
The diagnosis of invasive pulmonary aspergillosis (IPA) is challenging, and its incidence has been increasing in recent years due to emerging risk factors such as novel cancer therapies, prolonged corticosteroid use, and viral pneumonia. This case involves a 55-year-old male with hypopharyngeal cancer (cT2N2bM0, stage Iva), who had previously undergone concurrent chemoradiotherapy. He was hospitalized due to fever (39.3°C), cough, and purulent sputum. Laboratory tests revealed leukocytosis, and chest X-ray showed consolidation in the right upper lobe. Initially diagnosed as community-acquired pneumonia, he did not respond to empirical antibiotic therapy, and symptoms worsened. Follow-up chest X-ray and CT scan showed progression of the consolidation with cavitation and the presence of the air crescent sign. Sputum cultures were negative for pathogens. However, serum galactomannan (GM) was significantly elevated at 0.7, and bronchoalveolar lavage (BAL) GM index was also increased to 4.764, confirming the diagnosis of IPA. After treatment with voriconazole and levofloxacin, his symptoms improved and GM index decreased. He was discharged on oral voriconazole and remained stable during outpatient follow-up, highlighting the importance of early diagnosis and appropriate treatment in managing IPA. |